Limiting the DNA Damage Response's Damage
Studies Identify Contributors to Chemotherapy Resistance
By Anette Breindl
Tuesday, August 14, 2012
These days, the emergence of resistance to targeted therapies, with the result that such targeted therapies often produce remissions that are spectacular but ultimately short lived, are in the headlines.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.